217 related articles for article (PubMed ID: 31046160)
1. Prader-Willi syndrome: A model for understanding the ghrelin system.
Tauber M; Coupaye M; Diene G; Molinas C; Valette M; Beauloye V
J Neuroendocrinol; 2019 Jul; 31(7):e12728. PubMed ID: 31046160
[TBL] [Abstract][Full Text] [Related]
2. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.
Goldstone AP; Holland AJ; Butler JV; Whittington JE
Int J Obes (Lond); 2012 Dec; 36(12):1564-70. PubMed ID: 22270375
[TBL] [Abstract][Full Text] [Related]
3. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
4. High circulating ghrelin: a potential cause for hyperphagia and obesity in prader-willi syndrome.
DelParigi A; Tschöp M; Heiman ML; Salbe AD; Vozarova B; Sell SM; Bunt JC; Tataranni PA
J Clin Endocrinol Metab; 2002 Dec; 87(12):5461-4. PubMed ID: 12466337
[TBL] [Abstract][Full Text] [Related]
5. Prader-Willi syndrome as a model of human hyperphagia.
Tauber M; Diene G; Mimoun E; Çabal-Berthoumieu S; Mantoulan C; Molinas C; Muscatelli F; Salles JP
Front Horm Res; 2014; 42():93-106. PubMed ID: 24732928
[TBL] [Abstract][Full Text] [Related]
6. Maintenance of a normal meal-induced decrease in plasma ghrelin levels in children with Prader-Willi syndrome.
Bizzarri C; Rigamonti AE; Giannone G; Berardinelli R; Cella SG; Cappa M; Müller EE
Horm Metab Res; 2004 Mar; 36(3):164-9. PubMed ID: 15057669
[TBL] [Abstract][Full Text] [Related]
7. In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels.
Purtell L; Sze L; Loughnan G; Smith E; Herzog H; Sainsbury A; Steinbeck K; Campbell LV; Viardot A
Neuropeptides; 2011 Aug; 45(4):301-7. PubMed ID: 21722955
[TBL] [Abstract][Full Text] [Related]
8. Calorie seeking, but not hedonic response, contributes to hyperphagia in a mouse model for Prader-Willi syndrome.
Davies JR; Humby T; Dwyer DM; Garfield AS; Furby H; Wilkinson LS; Wells T; Isles AR
Eur J Neurosci; 2015 Aug; 42(4):2105-13. PubMed ID: 26040449
[TBL] [Abstract][Full Text] [Related]
9. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial.
Allas S; Caixàs A; Poitou C; Coupaye M; Thuilleaux D; Lorenzini F; Diene G; Crinò A; Illouz F; Grugni G; Potvin D; Bocchini S; Delale T; Abribat T; Tauber M
PLoS One; 2018; 13(1):e0190849. PubMed ID: 29320575
[TBL] [Abstract][Full Text] [Related]
10. Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia.
Kweh FA; Miller JL; Sulsona CR; Wasserfall C; Atkinson M; Shuster JJ; Goldstone AP; Driscoll DJ
Am J Med Genet A; 2015 Jan; 167A(1):69-79. PubMed ID: 25355237
[TBL] [Abstract][Full Text] [Related]
11. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
12. Development of the eating behaviour in Prader-Willi Syndrome: advances in our understanding.
McAllister CJ; Whittington JE; Holland AJ
Int J Obes (Lond); 2011 Feb; 35(2):188-97. PubMed ID: 20680019
[TBL] [Abstract][Full Text] [Related]
13. Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome.
Kuppens RJ; Diène G; Bakker NE; Molinas C; Faye S; Nicolino M; Bernoux D; Delhanty PJ; van der Lely AJ; Allas S; Julien M; Delale T; Tauber M; Hokken-Koelega AC
Endocrine; 2015 Dec; 50(3):633-42. PubMed ID: 25989955
[TBL] [Abstract][Full Text] [Related]
14. Importance of reward and prefrontal circuitry in hunger and satiety: Prader-Willi syndrome vs simple obesity.
Holsen LM; Savage CR; Martin LE; Bruce AS; Lepping RJ; Ko E; Brooks WM; Butler MG; Zarcone JR; Goldstein JM
Int J Obes (Lond); 2012 May; 36(5):638-47. PubMed ID: 22024642
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
16. Hyperghrelinemia does not accelerate gastric emptying in Prader-Willi syndrome patients.
Choe YH; Jin DK; Kim SE; Song SY; Paik KH; Park HY; Oh YJ; Kim AH; Kim JS; Kim CW; Chu SH; Kwon EK; Lee KH
J Clin Endocrinol Metab; 2005 Jun; 90(6):3367-70. PubMed ID: 15657368
[TBL] [Abstract][Full Text] [Related]
17. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
18. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
19. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin, peptide YY and their receptors: gene expression in brain from subjects with and without Prader-Willi syndrome.
Talebizadeh Z; Kibiryeva N; Bittel DC; Butler MG
Int J Mol Med; 2005 Apr; 15(4):707-11. PubMed ID: 15754036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
